Clinical Trials Browser

Phase 3 × OTHER × orelabrutinib × Clear all

NCT06496308 2024-07-11

Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment

Phase 3 Recruiting

Lymphoma, Mantle-Cell

NCT05351346 2023-03-24

Genotype-guided Treatment in DLBCL

Phase 3 Unknown

Lymphoma, Large B-Cell, Diffuse